東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Prevalence of prescribing evidence-b...

Hernandez, Jose Josue.

FindBook

Google Book

Amazon

博客來

Prevalence of prescribing evidence-based pharmacotherapy by dementia status among elderly residents of long-term care facilities in the United States.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Prevalence of prescribing evidence-based pharmacotherapy by dementia status among elderly residents of long-term care facilities in the United States./
作者:	Hernandez, Jose Josue.
面頁冊數:	137 p.
附註:	Adviser: Ilene H. Zuckerman.
Contained By:	Dissertation Abstracts International68-04B.
標題:	Health Sciences, Pharmacy. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3261582

Prevalence of prescribing evidence-based pharmacotherapy by dementia status among elderly residents of long-term care facilities in the United States.
Hernandez, Jose Josue.

Prevalence of prescribing evidence-based pharmacotherapy by dementia status among elderly residents of long-term care facilities in the United States. - 137 p.

Adviser: Ilene H. Zuckerman.

Thesis (Ph.D.)--University of Maryland, Baltimore, 2007.

Background. Risk factors associated with underprescribing, such as increasing age and dementia diagnosis, are highly prevalent among LTC residents. Despite being recognized as a highly prevalent problem among elderly persons, underprescribing of EBP has not been studied adequately among elderly persons residing in LTC facilities. The objective of this dissertation was to measure the prevalence of EBP prescribing among LTC elderly residents, as well as to determine if disparities in prescribing EBP exist by dementia and cognitive level.Subjects--Topical Terms:

1017737
Health Sciences, Pharmacy.

Prevalence of prescribing evidence-based pharmacotherapy by dementia status among elderly residents of long-term care facilities in the United States.
LDR:03292nam 2200301 a 45 001 945909
005 20110523
008 110523s2007 ||||||||||||||||| ||eng d
035 $a (UMI)AAI3261582
035 $a AAI3261582
040 $a UMI $c UMI
100 1 $a Hernandez, Jose Josue. $3 1269316
245 1 0 $a Prevalence of prescribing evidence-based pharmacotherapy by dementia status among elderly residents of long-term care facilities in the United States.
300 $a 137 p.
500 $a Adviser: Ilene H. Zuckerman.
500 $a Source: Dissertation Abstracts International, Volume: 68-04, Section: B, page: 2283.
502 $a Thesis (Ph.D.)--University of Maryland, Baltimore, 2007.
520 $a Background. Risk factors associated with underprescribing, such as increasing age and dementia diagnosis, are highly prevalent among LTC residents. Despite being recognized as a highly prevalent problem among elderly persons, underprescribing of EBP has not been studied adequately among elderly persons residing in LTC facilities. The objective of this dissertation was to measure the prevalence of EBP prescribing among LTC elderly residents, as well as to determine if disparities in prescribing EBP exist by dementia and cognitive level.
520 $a Methods. A longitudinal cohort at the resident-month level was assembled from a nationally representative sample of Medicare LTC residents. Resident-months with a LTC facility stay of two or more consecutive days from January 1st 2000 to December 31 st 2002 were included in the study. Selected resident-months were retrospectively tested for the presence of each one of seven specific conditions needed to be treated with EBP, and subsequently evaluated for the prevalence of EBP prescribing. A generalized estimating equations procedure was used to study the association between dementia diagnosis, level of cognitive impairment, and prescribing EBP.
520 $a Results. 1,938 LTC residents were eligible for inclusion. Mean age was 85 years; 72% were female. The highest EBP prevalence was found for the use of a bowel regimen if receiving opioids (73%) and the lowest EBP was found for the use of beta-blockers among residents with CHF (17%). Resident-months with dementia and/or moderate to severe level of cognitive impairment were not statistically significantly associated with EBP. Increasing age (OR=0.78; 95% CI=0.62, 0.98) and higher comorbidity level (OR=0.71; 95% CI=0.52, 0.98) were statistically significantly associated with lower odds of receiving all of the indicated EBP.
520 $a Conclusion. The prevalence of EBP among US LTC residents is below what is considered to be optimal among those with and without dementia. The EBP therapies tested in this study have been shown to increase quality of life and to decrease hospitalizations and mortality among elderly patients. However, the low prevalence of EBP in this LTC population suggests that complex care issues associated with age give rise to challenges in defining and implementing "best" care approaches.
590 $a School code: 0373.
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Health Sciences, Public Health. $3 1017659
690 $a 0572
690 $a 0573
710 2 $a University of Maryland, Baltimore. $3 1029166
773 0 $t Dissertation Abstracts International $g 68-04B.
790 $a 0373
790 1 0 $a Zuckerman, Ilene H., $e advisor
791 $a Ph.D.
792 $a 2007
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3261582